Effect of chromosomal abnormality on survival in Myeloma IX patients. The effect of loss of 1p32.3 (FAF1/CDKN2C n = 866, A), gain of 1q (CKS1B n = 909, B), deletion of 13q (RB1 n = 1058, C), and deletion of 17p (TP53 n = 1016, D) on overall survival (months).